Skip to main content
logo
Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
124.89
-1.40 (-1.11%)
At close: Sep 8, 2026, 4:00 PM EDT
126.00
-0.29 (-0.23%)
After-hours: Sep 8, 2026, 7:30 PM EDT

Insmed Revenue

Insmed had revenue of $425.49M in the quarter ending June 30, 2026, with 296.11% growth. This brings the company's revenue in the last twelve months to $1.14B, up 185.76% year-over-year. In the year 2025, Insmed had annual revenue of $606.42M with 66.73% growth.

Revenue (ttm)
$1.14B
Revenue Growth
+185.76%
P/S Ratio
23.97
Revenue / Employee
$683,675
Employees
1,664
Market Cap
27.27B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025606.42M242.72M66.73%
Dec 31, 2024363.71M58.50M19.17%
Dec 31, 2023305.21M59.85M24.39%
Dec 31, 2022245.36M56.90M30.19%
Dec 31, 2021188.46M24.05M14.63%
Dec 31, 2020164.41M27.95M20.48%
Dec 31, 2019136.47M126.63M1,287.56%
Dec 31, 20189.84M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 201311.50M--
Dec 31, 2012---
Dec 31, 20114.42M-2.50M-36.18%
Dec 31, 20106.92M-3.45M-33.28%
Dec 31, 200910.37M-1.33M-11.33%
Dec 31, 200811.70M4.12M54.32%
Dec 31, 20077.58M6.56M639.61%
Dec 31, 20061.03M894.00K682.44%
Dec 31, 2005131.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
BeOne Medicines AG6.13B
Incyte5.82B
Alnylam Pharmaceuticals4.80B
Jazz Pharmaceuticals4.60B
Genmab4.13B
BioNTech SE3.03B
Royalty Pharma2.54B
Ascendis Pharma1.20B
Revenue Rankings

INSM News

More News